Latest Market News

360 Capital Mortgage REIT has secured a new $9.2 million senior loan and extended a $17.6 million facility, enhancing its portfolio diversification and maintaining its FY25 distribution guidance.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

The ASX has formally queried Bougainville Copper Limited following an unexpected surge in its share price and trading volume, seeking clarity on any undisclosed information that might explain the market activity.

Kingston Resources has agreed to sell its Misima Gold-Silver Project for $95 million, bolstering its balance sheet to accelerate growth at the Mineral Hill gold-copper operation. The transaction positions Kingston to expand production and exploration in the southern Cobar Basin.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Sunstone Metals Ltd has had its trading suspension lifted following a Federal Court decision and the release of a cleansing prospectus, signaling a fresh chapter for the mining company on the ASX.

Metro Mining’s latest update reveals a decline in Ore Reserves and Resources at Bauxite Hills Mine due to 2024 mining activity, with no new exploration additions. The company plans a significant capital expansion to boost production capacity.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Whitefield Industrials Limited reported a 10% increase in core operating profit for the year ended March 2025, outperforming its benchmark with a 7.5% portfolio return and raising fully franked dividends to 10.5 cents per share.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Zoono Group has inked a five-year exclusive contract with Sharpak and OSY to apply its antimicrobial technology on UK soft fruit packaging, aiming to reduce food waste and boost shelf-life.